29 results
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:56am
, or IND, application to the FDA and MOH. See “– Research and Clinical Development Strategy – Clinical Development Plan” for additional information … for drug products.
Research and Clinical Development Strategy
Research and clinical development of our pharmaceutical drug product candidates is our
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:55am
an Investigational New Drug, or IND, application to the FDA and MOH. See “– Research and Clinical Development Strategy – Clinical Development Plan … the FDA’s regulatory pathway for drug products.
Research and Clinical Development Strategy
Research and clinical development of our pharmaceutical
POS AM
RAPH
Raphael Pharmaceutical Inc.
4 May 23
Prospectus update (post-effective amendment)
4:01pm
on submitting an Investigational New Drug, or IND, application to the FDA and MOH. See “– Research and Clinical Development Strategy – Clinical Development Plan … using the FDA’s regulatory pathway for drug products.
Research and Clinical Development Strategy
Research and clinical development of our
POS AM
RAPH
Raphael Pharmaceutical Inc.
2 May 23
Prospectus update (post-effective amendment)
4:02pm
an Investigational New Drug, or IND, application to the FDA and MOH. See “– Research and Clinical Development Strategy – Clinical Development Plan … the FDA’s regulatory pathway for drug products.
Research and Clinical Development Strategy
Research and clinical development of our pharmaceutical
POS AM
59c i5btu
26 May 22
Prospectus update (post-effective amendment)
9:28am
10-12G/A
ky2n3dd4quadh
23 Sep 21
Registration of securities (amended)
6:19am
10-12G/A
fulmko 490a3
2 Sep 21
Registration of securities (amended)
5:28pm
CORRESP
nrax0670ljufuyt8brf
2 Sep 21
Correspondence with SEC
12:00am
UPLOAD
gcoyyy36kain66 den
31 Aug 21
Letter from SEC
12:00am
10-12G
yngybvj
29 Jul 21
Registration of securities
12:00am
10-12G/A
lser8qnfo n5
2 Jul 21
Registration of securities (amended)
4:15pm
10-12G
nygf bkb6
14 May 21
Registration of securities
5:27pm
10-K
dhe5z5mzr eqel
27 Mar 09
Annual report
12:00am